FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

3691311000001109: Disopyramide 150mg modified-release tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22087701000001115 Disopyramide 150mg modified-release tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22087801000001112 Disopyramide 150mg modified-release tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Disopyramide 150mg modified-release tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Is pack of Disopyramide 150mg m/r tablet false Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has active ingredient Disopyramide phosphate false Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has active ingredient Disopyramide false Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has VMP Disopyramide 150mg m/r tablet false Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has specific active ingredient Disopyramide phosphate true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has VMP Disopyramide 150mg modified-release tablets false Inferred relationship Existential restriction modifier
Disopyramide 150mg modified-release tablets 100 tablet Has VMP Disopyramide 150mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Is a True Disopyramide 150mg modified-release tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start